The story has been updated to correct the market size figure for BioFire Diagnostics' GI and respiratory tests and to correct the previous name of the company.

NEW YORK (GenomeWeb News) – Though it is a relatively new player in the molecular diagnostics space, Salt Lake City-based BioFire Diagnostics sees "tremendous opportunity" for growth during the next 12 to 24 months, its CEO said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.